Skip to main content
. 2017 Mar 23;8(17):29258–29268. doi: 10.18632/oncotarget.16491

Table 3. Liver Function Changes 4 Weeks after Treatment in the TACE-125I Group.

Liver Function Test Pretreatment 4 Weeks after Treatment P Value*
Total bilirubin level(μmol/L) 21.3±5.2 42.5±3.5 .023
Albumin level (g/L) 35.2±3.1 36.1±2.1 .053
Prothrombin time (sec) 12.8±0.5 13.2±0.4 .062

Note: Unless indicated, date are mean±standard deviation.

*Paired-Samples T test was used